Dr. Michael Scott Berlowitz - NPI #1902871817

Cardiovascular Disease Doctor located in Tampa, FL

Florida Tampa Cardiovascular Disease Dr. Michael Scott Berlowitz Information


Dr. Michael Scott Berlowitz is a male Cardiovascular Disease Doctor (taxonomy code 207RC0000X) located in Tampa, Florida. Dr. Michael Scott Berlowitz primarily specializes in Cardiovascular Disease but also specializes in and Interventional Cardiology. Dr. Michael Scott Berlowitz's NPI Number is #1902871817 and has been listed in the NPI registry for 12 years. Dr. Michael Scott Berlowitz's practice location is listed as: 2 Tampa General Cir Stc 3Rd Floor Tampa, FL 33606-3603 and can be reached via phone at (813) 259-0600.

Cardiovascular Disease Taxonomy

The taxonomy code for Dr. Michael Scott Berlowitz's main specialty, Cardiovascular Disease, is 207RC0000X. An internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms.



Be the first to rate Dr. Berlowitz

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1902871817
 Phone (813) 259-0600
 Fax (813) 259-8676
2 Tampa General Cir
Stc 3Rd Floor
Tampa, FL 33606-3603
 Gender M
 Website Not provided
  • Cardiovascular Disease (FL)
  • Interventional Cardiology (NY)
Business Information
  • Sole Proprietor? No
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 2/23/2011
 Added 2/22/2006
 Viewed on 3/22/2018
Health Care Providers Nearby

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.